Browsing by Author Özdoğu, Hakan

Showing results 1 to 13 of 13
Issue DateTitleAuthor(s)
2014Comparison of ishage-based CD34 (+) cell enumeration protocols on BD facs canto ıı and attune flow cytometersKozanoğlu, İlknur; Ünver, Gülşah; Sarıtürk, Çağla; Baran, Yusuf ; Yeral, Mahmut; Boğa, Can; Özdoğu, Hakan
2013Cytotoxic effects of apigenin on multiple myeloma cellsBaran, Yusuf ; Yılmaz, S.; Cincin, Zeynep; Kozanoğlu, İlknur; Çakmakoğlu, Bedia; Özdoğu, Hakan
2013Diagnostic and therapeutic potentials of expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant chronic myeloid leukemia patientsBaran, Yusuf ; Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali
2015Discovering alternative targets in chronic myeloid leukemia (CML): determination of expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant CML patientsKartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali; Baran, Yusuf 
2013Effects of apigenin on imatinin-sensitive and resistant chronic myeloid leukemia cellsBaran, Yusuf ; Solmaz, Soner; Gökbulut, Aysun; Kozanoğlu, İlknur; Özdoğu, Hakan
2014Expression levels of ceramide-generating and clearance genes in newly diagnosed and tyrosine kinase inhibitor-resistant chronic myeloid leukemia patients: An attempt to find novel targetsKartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali; Saydam, Güray; Baran, Yusuf 
2014Expression levels of ceramide-metabolising genes in newly diagnosed and tyrosine kinase inhibitor-resistant chronic myeloid leukemia (CML) patients: The discovery of novel targets in CMLYandım, Melis Kartal; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, O.; Özcan, Mehmet Ali; Saydam, Göksel; Baran, Yusuf 
2015Expression levels of JAK/STAT signaling genes in newly diagnosed, drug sensitive and resistant chronic myeloid leukemia patientsKiraz, Yağmur; Saydam, Güray; Şahin, Fahri; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Baran, Yusuf 
2013Immunologically detection of BCR/ABL fusion protein with flow cytometry in K562 chronic myeloid leukemia cells and comparison with rt-pcr resultsKozanoğlu, İlknur; Aygün, B.; Boğa, I.; Cansun, C.; Üstündağ, N.; Baran, Yusuf ; Özdoğu, Hakan
2014JAK/STAT Signalling pathway genes in the regulation of tyrosine kinase inhibitors induced and clinical process in chronic myeloid leukemia patientsKiraz, Yağmur; Yandım, Melis Kartal; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, I.; Özcan, Mehmet Ali; Saydam, Göksel; Şahin, Fahri; Avcu, Ferit; Ural, Ali Uğur; Ünal, Ali; Baran, Yusuf 
Feb-2013New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myelomaKozanoğlu, İlknur; Kartal Yandım, Melis; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Çakmakoğlu, Bedia; Baran, Yusuf 
2014A novel biomarker for drug resistance in chronic myeloid leukemia: MicroRNA-17Baran, Yusuf ; Fıratlıgil, B.; Yandım, Melis Kartal; Kiraz, Yağmur; Kozanoglu, İlknur; Özdoğu, Hakan; Ünal, Ali
May-2014Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cellsSolmaz, Soner; Adan Gökbulut, Aysun; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Boğa, Can; Çakmakoğlu, Bedia; Kozanoğlu, İlknur; Baran, Yusuf